Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.
Bazarbachi A, Labopin M, Ghavamzadeh A, Giebel S, Al-Zahrani H, Ladeb S, Leone G, Abdel-Rahman F, Liso V, Hamidieh AA, Rasheed W, Ibrahim A, Alabdulaaly A, Kyrcz-Krzemien S, Arnold R, Kharfan-Dabaja MA, Alimoghaddam K, Aljurf M, Mohty M. Bazarbachi A, et al. Among authors: giebel s. Bone Marrow Transplant. 2013 Aug;48(8):1065-9. doi: 10.1038/bmt.2013.1. Epub 2013 Jan 28. Bone Marrow Transplant. 2013. PMID: 23353802
Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing.
Giebel S, Giorgiani G, Martinetti M, Zecca M, Maccario R, Salvaneschi L, Holowiecki J, Locatelli F. Giebel S, et al. Bone Marrow Transplant. 2003 Jun;31(11):987-93. doi: 10.1038/sj.bmt.1704054. Bone Marrow Transplant. 2003. PMID: 12774049
The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation.
Giebel S, Maccario R, Lilleri D, Zecca M, Avanzini MA, Marconi M, Di Cesare Merlone A, Campanini G, Montagna D, Travaglino P, Gentile R, Telli S, Pagliara D, Holowiecki J, Locatelli F. Giebel S, et al. Bone Marrow Transplant. 2005 Sep;36(6):503-9. doi: 10.1038/sj.bmt.1705094. Bone Marrow Transplant. 2005. PMID: 16007103 Clinical Trial.
Imatinib therapy prior to myeloablative allogeneic stem cell transplantation.
Zaucha JM, Prejzner W, Giebel S, Gooley TA, Szatkowski D, Kałwak K, Wojnar J, Kruzel T, Balon J, Hołowiecki J, Hellmann A. Zaucha JM, et al. Among authors: giebel s. Bone Marrow Transplant. 2005 Sep;36(5):417-24. doi: 10.1038/sj.bmt.1705087. Bone Marrow Transplant. 2005. PMID: 16007105 Clinical Trial.
Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S, Nowak I, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Kyrcz-Krzemien S, Kusnierczyk P. Giebel S, et al. Leukemia. 2008 Nov;22(11):2129-30; discussion 2130-1. doi: 10.1038/leu.2008.108. Epub 2008 May 8. Leukemia. 2008. PMID: 18463675 No abstract available.
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.
Giebel S, Labopin M, Holowiecki J, Labar B, Komarnicki M, Koza V, Masszi T, Mistrik M, Lange A, Hellmann A, Vitek A, Pretnar J, Mayer J, Rzepecki P, Indrak K, Wiktor-Jedrzejczak W, Wojnar J, Krawczyk-Kulis M, Kyrcz-Krzemien S, Rocha V. Giebel S, et al. Ann Hematol. 2009 Oct;88(10):1005-13. doi: 10.1007/s00277-009-0719-5. Epub 2009 Mar 20. Ann Hematol. 2009. PMID: 19301005
Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P. Giebel S, et al. Eur J Haematol. 2009 Oct;83(4):343-56. doi: 10.1111/j.1600-0609.2009.01280.x. Epub 2009 Jun 2. Eur J Haematol. 2009. PMID: 19500138
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL.
Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB, Dombret H, Ribera JM, Piccaluga PP, Czerw T, Kyrcz-Krzemien S, Holowiecki J; Study Group for Adult ALL of the European Leukemia Net. Giebel S, et al. Bone Marrow Transplant. 2010 Jun;45(6):1095-101. doi: 10.1038/bmt.2009.308. Epub 2009 Oct 26. Bone Marrow Transplant. 2010. PMID: 19855438
Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT.
Giebel S, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Nowak I, Holowiecka A, Segatti A, Kyrcz-Krzemien S, Kusnierczyk P, Holowiecki J. Giebel S, et al. Bone Marrow Transplant. 2010 Jun;45(6):1022-30. doi: 10.1038/bmt.2009.384. Epub 2010 Feb 1. Bone Marrow Transplant. 2010. PMID: 20118994 Clinical Trial.
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.
Giebel S, Labopin M, Ehninger G, Beelen D, Blaise D, Ganser A, Bacigalupo A, Czerw T, Holowiecki J, Fagundes EM, Nowara E, Frassoni F, Rocha V; Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Giebel S, et al. Blood. 2010 Jul 8;116(1):122-8. doi: 10.1182/blood-2010-01-266478. Epub 2010 Apr 15. Blood. 2010. PMID: 20395416 Free article.
275 results